One Year With a Hybrid Closed-Loop System: What Real Patients Experienced

A hybrid closed-loop insulin pump is a device that automatically adjusts insulin delivery based on your blood sugar readings. The Medtronic 670G, approved by the FDA in 2016, was the first of its kind. It's sometimes called an 'artificial pancreas' because it mimics some of what a healthy pancreas does—sensing glucose and delivering insulin in response.

Unlike older insulin pumps that deliver a steady amount of insulin, hybrid closed-loop systems adjust doses moment by moment. You still need to tell the system about meals and carbohydrates you eat, and you manage it through a separate controller device.

Researchers at Joslin Clinic studied 71 adults with Type 1 diabetes who used the 670G system continuously from 2017 to 2019. At the start, these adults had an average A1C of 7.6%—a common target for many people with Type 1 diabetes. The team measured their blood sugar control and quality of life at the beginning and after one full year of use.

This study looked at what actually happened in daily life, not in a controlled lab setting. That means the results reflect how people really use the system, including times when they might switch out of automatic mode or not follow the ideal routine.

After 12 months, study participants' A1C dropped by an average of 0.3%. That may sound small, but in diabetes care, even small improvements matter because they reflect reduced blood sugar swings over months. The amount of time participants spent in their target blood sugar range increased by about 8 percentage points.

Interestingly, the system didn't need to run in automatic mode all the time to help. However, it worked better for people who used automatic mode more often. On average, participants kept the system in automatic mode about 64% of the time—meaning they manually controlled insulin delivery the rest of the time.

Beyond better numbers, people reported feeling better. Those using the system for a year reported significantly less worry about low blood sugar episodes—a reduction of about 25% on a validated worry scale. They also reported better physical functioning in their daily lives, with a 23% improvement on a standard health survey.

These quality-of-life improvements suggest that hybrid closed-loop systems offer real benefits beyond just glucose numbers. Fewer low-blood-sugar worries and better ability to do physical activities can meaningfully improve daily life for people managing Type 1 diabetes.

This real-world study shows that hybrid closed-loop systems can help adults with Type 1 diabetes achieve better blood sugar control and feel less anxious about lows over the course of a year. However, the improvements are gradual, not dramatic, and the system works best when users trust it enough to run it in automatic mode regularly.

If you're considering a hybrid closed-loop system, talk with your diabetes care team about whether it might fit your needs, lifestyle, and goals. Everyone's diabetes is different, and what works well for one person may need adjustment for another.

Origin: CBS News (News report). Evidence: News report, corroborated with 1 indexed study. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.